FIELD: chemistry.
SUBSTANCE: methyl ether of 16,16-dimethyl-2-fluoro-D-homo-8α-oestrone is synthesised, having hypolipidemic and cardioprotector activity in the absence of uterotropic and anti-gonadotropic action. The invention - methyl ether of 16,16-dimethyl-2-fluoro-D-homo-8α-oestrone - can be used in medicine to treat cardiovascular diseases.
EFFECT: possibility of using the invention in medicine.
1 cl, 3 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 17,17-DIMETHYL-D-HOMO-B-NOR-8α-OESTRONE HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2008 |
|
RU2391351C1 |
| 3-METHOXY-2-FLUORO-18-ETHYL-8α-GONA-1,3,5( 10 )-TRIENES, HAVING OSTEOPROTECTOR AND HYPOCHOLESTEREMIC ACTIVITY | 2009 |
|
RU2418000C1 |
| 3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD | 2018 |
|
RU2679625C1 |
| APPLICATION OF 3-O-SULFAMATE-16,16-DIMETHYL-D-HOMOEQUILININE FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2680603C1 |
| RACEMIC 3,17β-DIHYDROXY-7α,18-DIMETHYL-6-OXAEXTRA-1,3,5( 10 ),8(9)-TETRAENE DIACETATE EXHIBITING OSTEOPROTECTIVE, HYPOCHOLESTEREMIC AND ANTIOXIDANT ACTION | 2009 |
|
RU2422455C1 |
| PROCESS FOR PREPARING RACEMIC 8-ISOESTRADIOL | 0 |
|
SU1092158A1 |
| 13-ETHYL-GONA-1,3,5( 10), 8 (9)-TETRAENE-3,17β-DIOL DIACETATE, HAVING ANTI-IMPLANTATION AND ANTIOXIDANT ACTIVITY | 2010 |
|
RU2454424C1 |
| MEDICAL APPLICATIONS SELECTIVE ESTROGEN RECEPTOR MODULATORS IN COMBINATION WITH STEROID SEX HORMONE PRECURSORS | 1999 |
|
RU2246947C2 |
| NEW METHOD FOR SYNTHESIS OF 3-O-SULPHAMATE 16,16-DIMETHYL-D-HOMOEQUILENINE | 2021 |
|
RU2752064C1 |
| USING BELAMCANDA CHINENSIS EXTRACT AS ESTROGEN-LIKE ORGAN-SELECTIVE MEDICINAL PREPARATION WITHOUT UTEROTROPIC EFFECT | 1999 |
|
RU2263505C2 |
